Novel biomarkers in human terminal heart failure and under mechanical circulatory support

Bring on the biomarkers

(2011) George Poste   NATURE

Circulating Matrix Metalloproteinase-3 and Metalloproteinase-9 and Tissue Doppler Measures of Diastolic Dysfunction to Risk Stratify Patients With Systolic Heart Failure

(2010) Simona Buralli et al.   AMERICAN JOURNAL OF CARDIOLOGY

Combined use of bFGF and GDF-5 enhances the healing of medial collateral ligament injury

(2010) Kenta Saiga et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Growth differentiation factor 15 in different stages of heart failure: potential screening implications

(2010) Fangfang Wang et al.   BIOMARKERS

Circulating biomarkers of tissue remodelling in pulmonary hypertension

(2010) Christian Schumann et al.   BIOMARKERS

Imbalance of Matrix Metalloproteinases/Tissue Inhibitor of Metalloproteinase-1 and Loss of Fibronectin Expression in Patients with Congestive Heart Failure

(2010) Da-chun Yang et al.   CARDIOLOGY

Growth/differentiation Factor-5 Induces Osteogenic Differentiation of Human Ligamentum Flavum Cells through Activation of ERK1/2 and p38 MAPK

(2010) Zhao-Ming Zhong et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

(2010) Dirk J. A. Lok et al.   Clinical Research in Cardiology

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

(2010) Ravi V. Shah et al.   EUROPEAN JOURNAL OF HEART FAILURE

Mice with Tissue Inhibitor of Metalloproteinases 4 (Timp4) Deletion Succumb to Induced Myocardial Infarction but Not to Cardiac Pressure Overload

(2010) Ilpo Koskivirta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Long-Term Continuous Flow Left Ventricular Assist Device Support and End-Organ Function: Prospects for Destination Therapy

(2010) Mark S. Slaughter   JOURNAL OF CARDIAC SURGERY

181: Plasma Galectin 3 Is Increased in Terminal Heart Failure Patients and Is Elevated in Patients Not Surviving Mechanical Circulatory Support

(2010) G. Erkilet et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Growth Differentiation Factor 5 Regulates Cardiac Repair After Myocardial Infarction

(2010) Syed H.E. Zaidi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Destination Therapy: Safety and Feasibility of National and International Travel

(2009) Laura A. Coyle et al.   ASAIO JOURNAL

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assay

(2009) Benjamin Dieplinger et al.   CLINICA CHIMICA ACTA

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy

(2009) P. W.X. Foley et al.   EUROPEAN HEART JOURNAL

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction

(2009) S. Q. Khan et al.   EUROPEAN HEART JOURNAL

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover

(2009) Ramón Martos et al.   EUROPEAN JOURNAL OF HEART FAILURE

Expression of Extracellular Matrix Genes During Myocardial Recovery From Heart Failure After Left Ventricular Assist Device Support

(2009) Leanne E. Felkin et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device

(2009) Mark S. Slaughter et al.   NEW ENGLAND JOURNAL OF MEDICINE

N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin

(2008) Yun-He Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Plasma concentrations of matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-1 and osteopontin reflect severity of heart failure in DOCA-salt hypertensive rat

(2008) Frank Kramer et al.   BIOMARKERS

Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial Infarction

(2008) Marc S. Sabatine et al.   CIRCULATION

Increased Plasma Concentrations of Soluble ST2 are Predictive for 1-Year Mortality in Patients with Acute Destabilized Heart Failure

(2008) T. Mueller et al.   CLINICAL CHEMISTRY

IL-1, IL-18, and IL-33 families of cytokines

(2008) William P. Arend et al.   IMMUNOLOGICAL REVIEWS

Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices

(2008) Hendrik Milting et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Which Factors Predict the Recovery of Natural Heart Function After Insertion of a Left Ventricular Assist System?

(2008) A. Mano et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure

(2008) Shafiq U. Rehman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The regulation of matrix metalloproteinases and their inhibitors

(2007) I CLARK et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Metalloproteinases and their inhibitors: Regulators of wound healing

(2007) S GILL et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Matrix metalloproteinases as modulators of inflammation

(2007) A MANICONE et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY